EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Upgrading right ventricular pacemakers to biventricular pacing or conduction system pacing: a systematic review and meta-analysis

Nandita Kaza iD, Varanand Htun, Alejandra Miyazawa iD, Florentina Simader iD, Bradley Porter, James P Howard iD, Ahran D Arnold iD, Akriti Naraen iD, David Luria, Michael Glikson iD, Carsten Israel, Darrel P Francis iD und 3 weitere

EP Europace · 30.03.2023 · 25 (3) · 1077-1086

DOI: 10.1093/europace/euac188 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift EP Europace, online erschienen am 10.11.2022. Verfasst von Nandita Kaza und 14 weiteren Autor:innen. Beteiligte Einrichtung: National Heart and Lung Institute, Imperial College London, B Block, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK. Hauptthemen laut MEDLINE: Cardiac Resynchronization Therapy, Pacemaker, Artificial, Ventricular Dysfunction, Left, Heart Failure. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Guidelines recommend patients undergoing a first pacemaker implant who have even mild left ventricular (LV) impairment should receive biventricular or conduction system pacing (CSP). There is no corresponding recommendation for patients who already have a pacemaker. We conducted a meta-analysis of randomized controlled trials (RCTs) and observational studies assessing device upgrades. The primary outcome was the echocardiographic change in LV ejection fraction (LVEF). Six RCTs (randomizing 161 patients) and 47 observational studies (2644 patients) assessing the efficacy of upgrade to biventricular pacing were eligible for analysis. Eight observational studies recruiting 217 patients of CSP upgrade were also eligible. Fourteen additional studies contributed data on complications (25 412 patients). Randomized controlled trials of biventricular pacing upgrade showed LVEF improvement of +8.4% from 35.5% and observational studies: +8.4% from 25.7%. Observational studies of left bundle branch area pacing upgrade showed +11.1% improvement from 39.0% and observational studies of His bundle pacing upgrade showed +12.7% improvement from 36.0%. New York Heart Association class decreased by −0.4, −0.8, −1.0, and −1.2, respectively. Randomized controlled trials of biventricular upgrade found improvement in Minnesota Heart Failure Score (−6.9 points) and peak oxygen uptake (+1.1 mL/kg/min). This was also seen in observational studies of biventricular upgrades (−19.67 points and +2.63 mL/kg/min, respectively). In studies of the biventricular upgrade, complication rates averaged 2% for pneumothorax, 1.4% for tamponade, and 3.7% for infection over 24 months of mean follow-up. Lead-related complications occurred in 3.3% of biventricular upgrades and 1.8% of CSP upgrades. Randomized controlled trials show significant physiological and symptomatic benefits of upgrading pacemakers to biventricular pacing. Observational studies show similar effects between biventricular pacing upgrade and CSP upgrade.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac Resynchronization TherapyPacemaker, ArtificialVentricular Dysfunction, LeftHeart FailureHumansCardiac Pacing, ArtificialCardiac Conduction System DiseaseHeart Conduction SystemVentricular Function, LeftStroke VolumeTreatment Outcome

Stichwörter der Autor:innen

Biventricular pacingConduction system pacingPhysiological pacingUpgrade

Autor:innen und Institutionen

  • National Heart and Lung Institute, Imperial College London, B Block, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK.
  • School of Public Health, Imperial College London, London, UK.
  • Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Warrington and Halton Hospitals NHS Foundation Trust, Liverpool, UK.
  • Hebrew University Jerusalem, Jerusalem, Israel.
  • Shaare Zadek Medical Center, Jerusalem, Israel.

ORCID-Profile: Nandita Kaza, Alejandra Miyazawa, Florentina Simader, James P Howard, Ahran D Arnold, Akriti Naraen, Michael Glikson, Darrel P Francis, Zachary I Whinnett, Matthew J Shun-Shin, Daniel Keene

Förderung

  • British Heart Foundation

Zitieren

APA

Kaza, N., Htun, V., Miyazawa, A., Simader, F., Porter, B., Howard, J. P., Arnold, A. D., Naraen, A., Luria, D., Glikson, M., Israel, C., Francis, D. P., Whinnett, Z. I., Shun-Shin, M. J., & Keene, D. (2023). Upgrading right ventricular pacemakers to biventricular pacing or conduction system pacing: a systematic review and meta-analysis. EP Europace, 25(3), 1077-1086. https://doi.org/10.1093/europace/euac188

Vancouver

Kaza N, Htun V, Miyazawa A, Simader F, Porter B, Howard JP, et al. Upgrading right ventricular pacemakers to biventricular pacing or conduction system pacing: a systematic review and meta-analysis. EP Europace. 2023;25(3):1077-1086. doi:10.1093/europace/euac188

BibTeX
@article{Kaza2023,
  author = {Kaza, Nandita and Htun, Varanand and Miyazawa, Alejandra and Simader, Florentina and Porter, Bradley and Howard, James P and Arnold, Ahran D and Naraen, Akriti and Luria, David and Glikson, Michael and Israel, Carsten and Francis, Darrel P and Whinnett, Zachary I and Shun-Shin, Matthew J and Keene, Daniel},
  title = {Upgrading right ventricular pacemakers to biventricular pacing or conduction system pacing: a systematic review and meta-analysis},
  journal = {EP Europace},
  year = {2023},
  volume = {25},
  number = {3},
  pages = {1077--1086},
  doi = {10.1093/europace/euac188}
}
Kostenlos starten →